Small-cap pharma stock rebounds from today’s low after this API update worth ₹250 crore
Sigachi Industries share price rebounded from its intraday low on Wednesday following the announcement of progress on a new combination of Active Pharmaceutical Ingredients (APIs) for Cystic Fibrosis (CF), which includes Vanzacaftor, Tezacaftor, and Deutivacaftor. The company projects a revenue potential of around ₹250 crore per year starting from the fourth quarter of FY2026–27, positioning…